Investment Opps

ANZ has announced it will allocate $850m of ANZ Capital Notes 3 under the bookbuild process and has set the margin over the 180 day BBSW at 3.6% p.a. The offer is open from February 5, use of proceeds are for general corporate purposes, and the Notes form part of ANZ’s ongoing capital management strategy. The Notes are Basel III – compliant Additional Tier 1 Capital under APRA’s current capital adequacy standards. Distributions are non-cumulative, based on a floating rate, and are subject to Payment Condition not existing, and ANZ’s discretion.

Discovery Asset Management Pty Ltd (Discovery) is a boutique funds management business specialising in Australian Small Companies equities investing.

Channel Capital provides 2 new, market leading SIV Solutions – the CC SIV Series 1 Fund and the CC SIV QLD Fund.

The Commonwealth of Australia is selling 100% of the securities in  Medibank Private Limited (MPL) by Initial Public Offer (IPO) of securities on the ASX. 2,754 million securities will be offered representing $4,269-$5,508m based on the lower and upper values of the indicative price range.   Indicative Price Range – A$1.55-2.00 per share Joint Lead Managers – Deutsche Bank AG Sydney Branch, Goldman Sachs Australia Pty Ltd and Macquarie Capital (Australia) Ltd. Co-Lead Managers- Bell Potter Securities Limited, Commonwealth Bank of Australia, Morgans Financial Limited, UBS Wealth Management Australia Limited. Co-Managers – Evans and Partners Pty Ltd, Ord Minnett Limited   Medibank is Australia’s largest private health insurer.   Retail offer 28 October- 14 November 2014 AEST Book build closes and Broker Sponsored Bids due 20 November 2014 12 Noon Listing 25 November 2014

Macquarie Bank announced its intention to raise A$400m (more or less), through the offer of Bank Capital Notes (BCN). The notes will be quoted on the ASX under the code MBLPA. They are fully paid, unsecured, subordinated, non-cumulative, mandatorily convertible notes issued by MBL at $100 per BCN. Distributions will be paid semi-annually in arrears subject to certain Payment Conditions. Indicative distribution rate is 180 day BBSW  plus margin in the range of 3.10-3.30%, and mandatory conversion into MGL shares is 24/3/2023 subject to certain conditions. The offer is made under a prospectus, and available only to investors resident in Australia and to certain institutional investors.   Macquarie Bank is Sole Arranger and a Joint Lead Manager. ANZ Securities Ltd, Citigroup Global Markets Australia Pty Ltd, Commonwealth Bank of Australia, Evans and Partners Pty Ltd, J.P. Morgan Australia Ltd, Morgans Financial Limited and National Australia Bank Ltd have also been appointed as JLMs. Broker firm offers close 5pm (Sydney Time), 7 October 2014.   For further information please see www.macquariebcnoffer.com.au For Australian Investors only, not for distribution in the United States.